Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06582927 · ClinicalTrials.gov registry record · NA

Mindfulness Training for First Responders

A NA study, sponsored by University of Miami.

Completed
Registry status
NA
Development phase
87
Enrollment target

NCT06582927: Completed NA study, sponsored by University of Miami.

NCT06582927 is a NA study that has completed, run by University of Miami. The registered enrollment target is 87 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06582927, a NA study, has completed, sponsored by University of Miami.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target

Study Summary

The present study evaluates the efficacy of Mindfulness-Based Attention Training on measures targeting cognitive abilities and emotional well-being in first responders.

Primary Outcome

The Sustained Attention to Response Task (SART) is used to assess attentional performance and mind wandering (i.e., off-task thinking which is typically self-generated and compromises the performance of the task at hand). The task uses a continuous performance paradigm involving button presses to frequently presented nontargets (numbers 0, 1, 2, 4, 5, 6, 7, 8, and 9) but requires the participants to withhold their motor response to the infrequent target (number 3). Withholding responses only to

Interventions

  • BEHAVIORAL Mindfulness-Based Attention Training (MBAT)

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2025-07-22
Est. Completion 2026-04-10
Phase NA
University of Miami

721 total trials

What the finished NCT06582927 record still lists

NCT06582927 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).

The record links to 0 conditions, and to 1 intervention - of which Mindfulness-Based Attention Training (MBAT) is the first listed.

NCT06582927 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06582927 about?

NCT06582927 is a clinical study titled "Mindfulness Training for First Responders". The present study evaluates the efficacy of Mindfulness-Based Attention Training on measures targeting cognitive abilities and emotional well-being in first responders.

What is the current status of trial NCT06582927?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2025-07-22. Estimated completion is 2026-04-10.

What interventions are being tested in trial NCT06582927?

The interventions under investigation include: Mindfulness-Based Attention Training (MBAT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06582927?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT06582927's enrollment target sits among peer trials

87 974th of 2000 higher than 1,025 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03292601 · 87 participants · NA

    Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)

  • NCT04291105 · 87 participants · Phase 2

    Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients

  • NCT04565795 · 87 participants · NA

    Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy

  • NCT05607004 · 87 participants · Phase 2

    (Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06582927, the US trial registry maintained by the National Library of Medicine. NCT06582927 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.